Inflammatory bowel disease (IBD) is a crowded drug market with plenty of treatment options across the two forms of the ...

The condition, which most often affects people in warm, humid climates where fungal spores are common, can trigger nasal ...

After spending much of the year sloping steadily downward from a January peak, TV drug ad spending picked up in a major way ...

Becoming a blockbuster in its third full year on the market put Gilead’s cancer treatment Trodelvy on a course to potentially justify the company’s $21 billion ...

As the prospect of import tariffs and drug price reform marshals billions of biopharma investment dollars into the U.S., the ...

Akeso has data showing ivonescimab can extend the lives of patients with previously treated EGFR-mutated non-small cell lung ...